Back to News
Market Impact: 0.38

Wells Fargo upgrades O-I Glass stock rating on valuation appeal By Investing.com

OIWFC
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsMarket Technicals & Flows
Wells Fargo upgrades O-I Glass stock rating on valuation appeal By Investing.com

Wells Fargo upgraded O-I Glass to Overweight but cut its 2026 and 2027 EBITDA estimates to $1.15B and $1.31B, after a first-quarter EPS of $0.05 missed the $0.16 consensus by 68.75%. Revenue of $1.54B slightly beat the $1.48B estimate, but guidance was reduced on weaker European fundamentals and higher energy costs. Shares are down 36% year-to-date and now trade at $9.49, near their 52-week low.

Analysis

The market is treating this as a classic “value trap or cyclical bottom” debate, but the more interesting read is that the earnings reset may be less about volume destruction than about margin leakage from Europe and input-cost pass-through. That matters because if the cost issue is transitory, the stock can re-rate quickly on even modest evidence of stabilization; if not, the multiple floor is lower than sell-side targets imply. The gap between revenue resilience and EPS collapse suggests operating leverage is still working in reverse, which is usually where bottoms form, but only after a second, cleaner guide-down. Second-order winners are likely adjacent packaging players with better geographic mix and pricing power, while losers are customers and suppliers exposed to softer container demand if OI defers capex and inventory rebuilds. A prolonged European weakness thesis also implies downstream glass converters and beverage packagers may get more aggressive on pricing, which can delay the normalization investors are underwriting. The key hidden variable is not demand alone, but whether the company can convert restructuring actions into visible quarterly EBITDA conversion before the market loses patience. The contrarian angle is that consensus may be underestimating the earnings torque from a low bar: at a sub-5x forward EV/EBITDA valuation, even incremental margin recovery can drive outsized equity upside if the business merely stops deteriorating. But the counterpoint is that the market rarely rewards “future savings” until they show up in reported numbers; one more weak quarter would likely push the stock from cheap to structurally impaired. For timing, the next 1-2 quarters matter far more than the 2027 model, because the stock is trading on credibility, not terminal value.